mRNA

News

Preparing for an influx of cell and gene therapy approvals

CapstanTx secures $165 million to deliver precise in vivo ce...

Yesterday, the biotechnology company Capstan Therapeutics launched with $165 million in seed and Series A funding for it to build on its foundational insights into precision in vivo

News

Glass Medicine Vials and botox, hualuronic, collagen or flu Syringe on a white background.

Pfizer, BioNTech's mRNA flu vaccine starts phase 3 testing

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy t

News

ESMO: Evidence builds for BioNTech's amplified CAR-T therapy

BioNTech has been thrust into the limelight with its mRNA-based vaccines and therapeutics – most notably its Pfizer-partnered COVID-19 shot – but the other side of its business is CAR-T the

R&D

Now is the time for pharma to help solve bias in clinical tr...

Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials.

Digital

Health Innovation Fund, Moderna’s largest shareholder, shares investment strategies

Baillie Gifford, Moderna’s largest shareholder, shares inves...

Jack Torrance, investment specialist for Baillie Gifford's Health Innovation Fund, tells us how the organisation ensures its investments will have the most significant positive impact on al

Podcasts